{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:51:04Z","timestamp":1787503864109,"version":"build-2736575974"},"reference-count":138,"publisher":"The Endocrine Society","issue":"7","license":[{"start":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T00:00:00Z","timestamp":1711584000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K08DK132463"],"award-info":[{"award-number":["K08DK132463"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The majority of disorders that cause renal potassium wasting present with abnormalities in adrenal hormone secretion. While these findings frequently lead patients to seek endocrine evaluation, clinicians often struggle to accurately diagnose these conditions, delaying treatment and adversely impacting patient care. At the same time, growing insight into the genetic and molecular basis of these disorders continues to improve their diagnosis and management. In this review, we outline a practical integrated approach to the evaluation of renal hypokalemia syndromes that are seen in endocrine practice while highlighting recent advances in understanding of the genetics and pathophysiology behind them.<\/jats:p>","DOI":"10.1210\/clinem\/dgae201","type":"journal-article","created":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T03:01:41Z","timestamp":1711508501000},"page":"1694-1706","source":"Crossref","is-referenced-by-count":5,"title":["Renal Hypokalemia: An Endocrine Perspective"],"prefix":"10.1210","volume":"109","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5839-6760","authenticated-orcid":false,"given":"Silas A","family":"Culver","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Department of Medicine, University of Virginia Health System , Charlottesville, VA 22908 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6537-7472","authenticated-orcid":false,"given":"Nawar","family":"Suleman","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Medicine, University of Virginia Health System , Charlottesville, VA 22908 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8792-8044","authenticated-orcid":false,"given":"Varun","family":"Kavuru","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Virginia Health System , Charlottesville, VA 22908 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8121-9052","authenticated-orcid":false,"given":"Helmy M","family":"Siragy","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Medicine, University of Virginia Health System , Charlottesville, VA 22908 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2024,3,28]]},"reference":[{"issue":"3","key":"2025052406571769200_dgae201-B1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/07315724.2020.1765893","article-title":"Rising trend of hypokalemia prevalence in the US population and possible food causes","volume":"40","author":"Sun","year":"2021","journal-title":"J Am Coll Nutr"},{"issue":"2","key":"2025052406571769200_dgae201-B2","first-page":"104","article-title":"Short-term mortality risk of serum potassium levels in hypertension: a retrospective analysis of nationwide registry data","volume":"38","author":"Krogager","year":"2016","journal-title":"Eur Heart J"},{"issue":"5","key":"2025052406571769200_dgae201-B3","doi-asserted-by":"crossref","first-page":"F817","DOI":"10.1152\/ajprenal.1998.274.5.F817","article-title":"Renal potassium transport: mechanisms and regulation","volume":"274","author":"Giebisch","year":"1998","journal-title":"Am J Physiol Ren Physiol"},{"issue":"1","key":"2025052406571769200_dgae201-B4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/ncpneph0689","article-title":"Mechanisms of disease: the kidney-specific chloride channels ClCKA and ClCKB, the Barttin subunit, and their clinical relevance","volume":"4","author":"Kr\u00e4mer","year":"2008","journal-title":"Nat Clin Pract Nephrol"},{"key":"2025052406571769200_dgae201-B5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/978-3-662-43596-0_7","volume-title":"Pediatric Nephrology","author":"Satlin","year":"2016"},{"issue":"3","key":"2025052406571769200_dgae201-B6","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1681\/ASN.2017060600","article-title":"Salt-losing tubulopathies in children: what's new, what's controversial?","volume":"29","author":"Kleta","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"2025052406571769200_dgae201-B7","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1007\/s00424-014-1470-x","article-title":"Coordinated regulation of TRPV5-mediated Ca2+ transport in primary distal convolution cultures","volume":"466","author":"van der Hagen","year":"2014","journal-title":"Pfl\u00fcg Arch Eur J Physiol"},{"key":"2025052406571769200_dgae201-B8","volume-title":"Harrison's Principles of Internal Medicine","author":"George","year":"2022"},{"issue":"6","key":"2025052406571769200_dgae201-B9","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.2215\/CJN.08580813","article-title":"Regulation of potassium homeostasis","volume":"10","author":"Palmer","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"2025052406571769200_dgae201-B10","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/bs.vh.2018.07.001","article-title":"Regulation of aldosterone secretion","volume":"109","author":"MacKenzie","year":"2019","journal-title":"Vitam Horm"},{"issue":"5","key":"2025052406571769200_dgae201-B11","first-page":"F674","article-title":"A role for T-type Ca2+ channels in the synergistic control of aldosterone production by ANG II and K+","volume":"276","author":"Chen","year":"1999","journal-title":"Am J Physiol"},{"key":"2025052406571769200_dgae201-B12","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3389\/fendo.2016.00072","article-title":"Role of ACTH and other hormones in the regulation of aldosterone production in primary aldosteronism","volume":"7","author":"El Ghorayeb","year":"2016","journal-title":"Front Endocrinol"},{"issue":"5","key":"2025052406571769200_dgae201-B13","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1210\/jcem-69-5-1028","article-title":"Adrenocorticotropin stimulation of aldosterone: prolonged continuous versus pulsatile infusion","volume":"69","author":"Seely","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2025052406571769200_dgae201-B14","first-page":"702","article-title":"Responses of aldosterone-producing adenomas to ACTH and angiotensins","volume":"92","author":"Saruta","year":"1979","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"3\u20134","key":"2025052406571769200_dgae201-B15","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3109\/07435809809032695","article-title":"ACTH receptor mRNA in human adrenocortical tumors: overexpression in aldosteronomas","volume":"24","author":"Arnaldi","year":"1998","journal-title":"Endocr Res"},{"key":"2025052406571769200_dgae201-B16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/bs.vh.2018.10.004","volume-title":"Aldosterone","author":"Valinsky","year":"2019"},{"issue":"4","key":"2025052406571769200_dgae201-B17","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1161\/01.HYP.0000259797.48382.b2","article-title":"Nongenomic actions of aldosterone on the renal tubule","volume":"49","author":"Good","year":"2007","journal-title":"Hypertension"},{"issue":"3","key":"2025052406571769200_dgae201-B18","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1091\/mbc.6.3.261","article-title":"Aldosterone modulates sodium kinetics of Na, K-ATPase containing an alpha 1 subunit in A6 kidney cell epithelia","volume":"6","author":"Beron","year":"1995","journal-title":"Mol Biol Cell"},{"issue":"2","key":"2025052406571769200_dgae201-B19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.5662\/wjm.v5.i2.55","article-title":"Bartter and gitelman syndromes: spectrum of clinical manifestations caused by different mutations","volume":"5","author":"Al Shibli","year":"2015","journal-title":"World J Methodol"},{"issue":"2","key":"2025052406571769200_dgae201-B20","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/ng0696-183","article-title":"Bartter's syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na\u2013K\u20132CI cotransporter NKCC2","volume":"13","author":"Simon","year":"1996","journal-title":"Nat Genet"},{"issue":"2","key":"2025052406571769200_dgae201-B21","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/ng1096-152","article-title":"Genetic heterogeneity of Barter's syndrome revealed by mutations in the K+ channel, ROMK","volume":"14","author":"Simon","year":"1996","journal-title":"Nat Genet"},{"issue":"3","key":"2025052406571769200_dgae201-B22","doi-asserted-by":"crossref","first-page":"e0173581","DOI":"10.1371\/journal.pone.0173581","article-title":"Poor phenotype-genotype association in a large series of patients with type III bartter syndrome","volume":"12","author":"Garc\u00eda Casta\u00f1o","year":"2017","journal-title":"PLoS One"},{"issue":"6863","key":"2025052406571769200_dgae201-B23","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/35107099","article-title":"Barttin is a Cl- channel \u03b2-subunit crucial for renal Cl- reabsorption and inner ear K+ secretion","volume":"414","author":"Est\u00e9vez","year":"2001","journal-title":"Nature"},{"issue":"19","key":"2025052406571769200_dgae201-B24","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1056\/NEJMoa1507629","article-title":"Polyhydramnios, transient antenatal bartter's syndrome, and MAGED2 mutations","volume":"374","author":"Laghmani","year":"2016","journal-title":"N Engl J Med"},{"issue":"9","key":"2025052406571769200_dgae201-B25","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1097\/01.ASN.0000025781.16723.68","article-title":"Functional characterization of a calcium-sensing receptor mutation in severe autosomal dominant hypocalcemia with a bartter-like syndrome","volume":"13","author":"Vargas-Poussou","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"2025052406571769200_dgae201-B26","author":"Orphanet: Bartter Syndrome"},{"issue":"8","key":"2025052406571769200_dgae201-B27","doi-asserted-by":"crossref","first-page":"F1037","DOI":"10.1152\/ajprenal.00639.2012","article-title":"Inherited secondary nephrogenic diabetes insipidus: concentrating on humans","volume":"304","author":"Bockenhauer","year":"2013","journal-title":"Am J Physiol Ren Physiol"},{"issue":"8","key":"2025052406571769200_dgae201-B28","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1681\/ASN.V1181449","article-title":"Mutations in the chloride channel gene CLCNKB as a cause of classic bartter syndrome","volume":"11","author":"Konrad","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"2025052406571769200_dgae201-B29","doi-asserted-by":"crossref","first-page":"e924527","DOI":"10.12659\/AJCR.924527","article-title":"Late-onset bartter syndrome type II due to a homozygous mutation in KCNJ1 gene: a case report and literature review","volume":"21","author":"Elfert","year":"2020","journal-title":"Am J Case Rep"},{"issue":"1","key":"2025052406571769200_dgae201-B30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1152\/physrev.2001.81.1.51","article-title":"Magnesium transport in the renal distal convoluted tubule","volume":"81","author":"Dai","year":"2001","journal-title":"Physiol Rev"},{"issue":"5","key":"2025052406571769200_dgae201-B31","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1291\/hypres.27.327","article-title":"A high prevalence of Gitelman's syndrome mutations in Japanese","volume":"27","author":"Tago","year":"2004","journal-title":"Hypertens Res"},{"issue":"1","key":"2025052406571769200_dgae201-B32","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3346\/jkms.2016.31.1.47","article-title":"Mutations in SLC12A3 and CLCNKB and their correlation with clinical phenotype in patients with gitelman and Gitelman-like syndrome","volume":"31","author":"Lee","year":"2016","journal-title":"J Korean Med Sci"},{"issue":"3","key":"2025052406571769200_dgae201-B33","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1006\/geno.1996.0388","article-title":"Molecular cloning, expression pattern, and chromosomal localization of the human Na\u2013Cl thiazide-sensitive cotransporter (SLC12A3)","volume":"35","author":"Mastroianni","year":"1996","journal-title":"Genomics"},{"issue":"11","key":"2025052406571769200_dgae201-B34","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nrneph.2011.138","article-title":"The mechanism of hypocalciuria with NaCl cotransporter inhibition","volume":"7","author":"Reilly","year":"2011","journal-title":"Nat Rev Nephrol"},{"issue":"10","key":"2025052406571769200_dgae201-B35","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1007\/s00467-019-04371-y","article-title":"Bartter and Gitelman syndromes: questions of class","volume":"35","author":"Besouw","year":"2020","journal-title":"Pediatr Nephrol"},{"issue":"6","key":"2025052406571769200_dgae201-B36","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1172\/JCI24134","article-title":"Enhanced passive Ca2+ reabsorption and reduced Mg2+ channel abundance explains thiazide-induced hypocalciuria and hypomagnesemia","volume":"115","author":"Nijenhuis","year":"2005","journal-title":"J Clin Invest"},{"issue":"1","key":"2025052406571769200_dgae201-B37","first-page":"1","article-title":"Renal calcium and magnesium handling in Gitelman syndrome","volume":"14","author":"Reyes","year":"2022","journal-title":"Am J Transl Res"},{"issue":"3","key":"2025052406571769200_dgae201-B38","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/ndt\/gfz172","article-title":"Loss of sodium chloride co-transporter impairs the outgrowth of the renal distal convoluted tubule during renal development","volume":"35","author":"Schnoz","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"2025052406571769200_dgae201-B39","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2012-007929","article-title":"Gitelman or bartter type 3 syndrome? A case of distal convoluted tubulopathy caused by CLCNKB gene mutation","volume":"2013","author":"Cruz","year":"2013","journal-title":"BMJ Case Rep"},{"issue":"1","key":"2025052406571769200_dgae201-B40","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/ng0196-24","article-title":"Gitelman's variant of Barter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na\u2013Cl cotransporter","volume":"12","author":"Simon","year":"1996","journal-title":"Nat Genet"},{"issue":"19","key":"2025052406571769200_dgae201-B41","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1056\/NEJMoa0810276","article-title":"Epilepsy, ataxia, sensorineural deafness, tubulopathy, and KCNJ10 mutations","volume":"360","author":"Bockenhauer","year":"2009","journal-title":"N Engl J Med"},{"issue":"12","key":"2025052406571769200_dgae201-B42","doi-asserted-by":"crossref","first-page":"E511","DOI":"10.1210\/jc.2010-0392","article-title":"The pharmacological characteristics of molecular-based inherited salt-losing tubulopathies","volume":"95","author":"Nozu","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2025052406571769200_dgae201-B43","doi-asserted-by":"crossref","first-page":"454","DOI":"10.2215\/CJN.02950906","article-title":"A thiazide test for the diagnosis of renal tubular hypokalemic disorders","volume":"2","author":"Colussi","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"2025052406571769200_dgae201-B44","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1093\/ndt\/gfn689","article-title":"Phenotype\u2013genotype correlation in antenatal and neonatal variants of Bartter syndrome","volume":"24","author":"Brochard","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"2025052406571769200_dgae201-B45","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.kint.2020.10.035","article-title":"Diagnosis and management of Bartter syndrome: executive summary of the consensus and recommendations from the European rare kidney disease reference network working group for tubular disorders","volume":"99","author":"Konrad","year":"2021","journal-title":"Kidney Int"},{"issue":"1","key":"2025052406571769200_dgae201-B46","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/cen.14104","article-title":"The challenges of diagnosis and management of Gitelman syndrome","volume":"92","author":"Urwin","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2025052406571769200_dgae201-B47","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2796.1989.tb00048.x","article-title":"Bartter's syndrome\u2013treatment with potassium, spironolactone and ACE-inhibitor","volume":"225","author":"Clementsen","year":"1989","journal-title":"J Intern Med"},{"issue":"9","key":"2025052406571769200_dgae201-B48","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1056\/NEJM200008313430915","article-title":"New treatment options for bartter's syndrome","volume":"343","author":"Kleta","year":"2000","journal-title":"N Engl J Med"},{"issue":"1","key":"2025052406571769200_dgae201-B49","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11255-019-02351-7","article-title":"Adjunctive Acetazolamide therapy for the treatment of Bartter syndrome","volume":"52","author":"Mazaheri","year":"2020","journal-title":"Int Urol Nephrol"},{"issue":"3","key":"2025052406571769200_dgae201-B50","doi-asserted-by":"crossref","first-page":"e0168638","DOI":"10.1371\/journal.pone.0168638","article-title":"Targeting gene expression to specific cells of kidney tubules in vivo, using adenoviral promoter fragments","volume":"12","author":"Watanabe","year":"2017","journal-title":"PLoS One"},{"issue":"5","key":"2025052406571769200_dgae201-B51","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2025052406571769200_dgae201-B52","doi-asserted-by":"crossref","first-page":"683","DOI":"10.7326\/L20-1097","article-title":"The unrecognized prevalence of primary aldosteronism","volume":"173","author":"Vaidya","year":"2020","journal-title":"Ann Intern Med"},{"issue":"1","key":"2025052406571769200_dgae201-B53","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1210\/clinem\/dgaa484","article-title":"International histopathology consensus for unilateral primary aldosteronism","volume":"106","author":"Williams","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2025052406571769200_dgae201-B54","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1161\/HYPERTENSIONAHA.119.14177","article-title":"Genetic, cellular, and molecular heterogeneity in adrenals with aldosterone-producing adenoma","volume":"75","author":"De Sousa","year":"2020","journal-title":"Hypertension"},{"issue":"9","key":"2025052406571769200_dgae201-B55","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1210\/clinem\/dgac408","article-title":"Histopathology and genetic causes of primary aldosteronism in young adults","volume":"107","author":"Nanba","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"6357","key":"2025052406571769200_dgae201-B56","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/355262a0","article-title":"A chimaeric 11 beta-hydroxylase\/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension","volume":"355","author":"Lifton","year":"1992","journal-title":"Nature"},{"issue":"22","key":"2025052406571769200_dgae201-B57","first-page":"1109","article-title":"Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone","volume":"95","author":"Sutherland","year":"1966","journal-title":"Can Med Assoc J"},{"issue":"3","key":"2025052406571769200_dgae201-B58","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41588-018-0048-5","article-title":"CLCN2 chloride channel mutations in familial hyperaldosteronism type II","volume":"50","author":"Scholl","year":"2018","journal-title":"Nat Genet"},{"issue":"6018","key":"2025052406571769200_dgae201-B59","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1126\/science.1198785","article-title":"K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension","volume":"331","author":"Choi","year":"2011","journal-title":"Science"},{"key":"2025052406571769200_dgae201-B60","doi-asserted-by":"crossref","first-page":"e06315","DOI":"10.7554\/eLife.06315","article-title":"Recurrent gain of function mutation in calcium channel CACNA1H causes early-onset hypertension with primary aldosteronism","volume":"4","author":"Scholl","year":"2015","journal-title":"eLife"},{"issue":"9","key":"2025052406571769200_dgae201-B61","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/ng.2695","article-title":"Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism","volume":"45","author":"Scholl","year":"2013","journal-title":"Nat Genet"},{"issue":"4","key":"2025052406571769200_dgae201-B62","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/ng.2550","article-title":"Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension","volume":"45","author":"Beuschlein","year":"2013","journal-title":"Nat Genet"},{"issue":"6","key":"2025052406571769200_dgae201-B63","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1210\/en.2015-2029","article-title":"Cellular pathophysiology of an adrenal adenoma-associated mutant of the plasma membrane Ca(2+)-ATPase ATP2B3","volume":"157","author":"Tauber","year":"2016","journal-title":"Endocrinology"},{"issue":"9","key":"2025052406571769200_dgae201-B64","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1038\/s41588-021-00906-y","article-title":"Somatic mutations of GNA11 and GNAQ in CTNNB1-mutant aldosterone-producing adenomas presenting in puberty, pregnancy or menopause","volume":"53","author":"Zhou","year":"2021","journal-title":"Nat Genet"},{"issue":"6","key":"2025052406571769200_dgae201-B65","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/s41588-023-01403-0","article-title":"Somatic mutations of CADM1 in aldosterone-producing adenomas and gap junction-dependent regulation of aldosterone production","volume":"55","author":"Wu","year":"2023","journal-title":"Nat Genet"},{"issue":"10","key":"2025052406571769200_dgae201-B66","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1038\/s41588-023-01498-5","article-title":"Somatic SLC30A1 mutations altering zinc transporter ZnT1 cause aldosterone-producing adenomas and primary aldosteronism","volume":"55","author":"Rege","year":"2023","journal-title":"Nat Genet"},{"issue":"6","key":"2025052406571769200_dgae201-B67","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1210\/jc.2016-4007","article-title":"Genetic and histopathologic intertumor heterogeneity in primary aldosteronism","volume":"102","author":"Omata","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2025052406571769200_dgae201-B68","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1161\/HYPERTENSIONAHA.119.13476","article-title":"Primary aldosteronism: KCNJ5 mutations and adrenocortical cell growth","volume":"74","author":"Yang","year":"2019","journal-title":"Hypertension"},{"issue":"11","key":"2025052406571769200_dgae201-B69","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1210\/clinem\/dgac530","article-title":"Aldosterone-producing adenomas of increased size are associated with higher steroidogenic activity","volume":"107","author":"Nakai","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"2025052406571769200_dgae201-B70","doi-asserted-by":"crossref","first-page":"830130","DOI":"10.3389\/fendo.2022.830130","article-title":"KCNJ5 somatic mutation is associated with higher aortic wall thickness and less calcification in patients with aldosterone-producing adenoma","volume":"13","author":"Lee","year":"2022","journal-title":"Front Endocrinol"},{"issue":"4","key":"2025052406571769200_dgae201-B71","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/HYPERTENSIONAHA.118.11086","article-title":"Cellular and genetic causes of idiopathic hyperaldosteronism","volume":"72","author":"Omata","year":"2018","journal-title":"Hypertension"},{"issue":"5","key":"2025052406571769200_dgae201-B72","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1210\/clinem\/dgac679","article-title":"Intra-individual variability of serum aldosterone and implications for primary aldosteronism screening","volume":"108","author":"Maciel","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2025052406571769200_dgae201-B73","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13148-022-01347-y","article-title":"Whole blood methylome-derived features to discriminate endocrine hypertension","volume":"14","author":"Armignacco","year":"2022","journal-title":"Clin Epigenetics"},{"issue":"6","key":"2025052406571769200_dgae201-B74","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1161\/HYPERTENSIONAHA.118.12064","article-title":"18-Oxocortisol synthesis in aldosterone-producing adrenocortical adenoma and significance of KCNJ5 mutation status","volume":"73","author":"Tezuka","year":"2019","journal-title":"Hypertension"},{"issue":"1","key":"2025052406571769200_dgae201-B75","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1161\/HYPERTENSIONAHA.115.06186","article-title":"Genotype-specific steroid profiles associated with aldosterone-producing adenomas","volume":"67","author":"Williams","year":"2016","journal-title":"Hypertension"},{"issue":"9","key":"2025052406571769200_dgae201-B76","doi-asserted-by":"crossref","first-page":"e2016209","DOI":"10.1001\/jamanetworkopen.2020.16209","article-title":"Use of steroid profiling combined with machine learning for identification and subtype classification in primary aldosteronism","volume":"3","author":"Eisenhofer","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"5","key":"2025052406571769200_dgae201-B77","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa2213169","article-title":"Phase 2 trial of baxdrostat for treatment-resistant hypertension","volume":"388","author":"Freeman","year":"2023","journal-title":"N Engl J Med"},{"issue":"10","key":"2025052406571769200_dgae201-B78","doi-asserted-by":"crossref","first-page":"4695","DOI":"10.1210\/jc.2019-00531","article-title":"KCNJ5 somatic mutation is a predictor of hypertension remission after adrenalectomy for unilateral primary aldosteronism","volume":"104","author":"Vilela","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2025052406571769200_dgae201-B79","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/HJH.0000000000001578","article-title":"KCNJ5 mutation as a predictor for resolution of hypertension after surgical treatment of aldosterone-producing adenoma","volume":"36","author":"Kitamoto","year":"2018","journal-title":"J Hypertens"},{"issue":"1","key":"2025052406571769200_dgae201-B80","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1161\/HYPERTENSIONAHA.120.15679","article-title":"KCNJ5 somatic mutations in aldosterone-producing adenoma are associated with a worse baseline status and better recovery of left ventricular remodeling and diastolic function","volume":"77","author":"Chang","year":"2021","journal-title":"Hypertension"},{"issue":"3","key":"2025052406571769200_dgae201-B81","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1530\/EJE-21-0338","article-title":"Somatic mutations in adrenals from patients with primary aldosteronism not cured after adrenalectomy suggest common pathogenic mechanisms between unilateral and bilateral disease","volume":"185","author":"Hacini","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2025052406571769200_dgae201-B82","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ecl.2011.01.004","article-title":"Low-renin hypertension of childhood","volume":"40","author":"Parsa","year":"2011","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"1","key":"2025052406571769200_dgae201-B83","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0889-8529(08)70021-5","article-title":"The genetics, pathophysiology, and management of human deficiencies of P450c17","volume":"30","author":"Auchus","year":"2001","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"2","key":"2025052406571769200_dgae201-B84","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/ng1097-201","article-title":"The genetic and functional basis of isolated 17,20-lyase deficiency","volume":"17","author":"Geller","year":"1997","journal-title":"Nat Genet"},{"issue":"9","key":"2025052406571769200_dgae201-B85","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.1210\/jcem.86.9.7812","article-title":"Pitfalls in characterizing P450c17 mutations associated with isolated 17,20-lyase deficiency","volume":"86","author":"Gupta","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2025052406571769200_dgae201-B86","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ecl.2017.01.008","article-title":"Genetics of congenital adrenal hyperplasia","volume":"46","author":"Hannah-Shmouni","year":"2017","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"2","key":"2025052406571769200_dgae201-B87","first-page":"144","article-title":"Pregnancy outcomes in in vitro fertilization in 17-alpha-hydroxylase deficiency","volume":"4","author":"van Oosbree","year":"2023","journal-title":"FS Rep"},{"issue":"2","key":"2025052406571769200_dgae201-B88","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/s41371-017-0002-5","article-title":"Congenital adrenal hyperplasia causing hypertension: an illustrative review","volume":"32","author":"Hinz","year":"2018","journal-title":"J Hum Hypertens"},{"issue":"1","key":"2025052406571769200_dgae201-B89","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s12020-016-1189-x","article-title":"Clinical perspectives in congenital adrenal hyperplasia due to 11\u03b2-hydroxylase deficiency","volume":"55","author":"Bulsari","year":"2017","journal-title":"Endocrine"},{"key":"2025052406571769200_dgae201-B90","doi-asserted-by":"crossref","first-page":"1015973","DOI":"10.3389\/fendo.2022.1015973","article-title":"Challenges in the treatment of late-identified untreated congenital adrenal hyperplasia due to CYP11B1 deficiency: lessons from a developing country","volume":"13","author":"Utari","year":"2022","journal-title":"Front Endocrinol"},{"key":"2025052406571769200_dgae201-B91","doi-asserted-by":"crossref","first-page":"105882","DOI":"10.1016\/j.jsbmb.2021.105882","article-title":"Compound heterozygosity of a novel Q73X mutation and a known R141X mutation in CYP11B1 resulting in 11\u03b2-hydroxylase deficiency in a Chinese boy with congenital adrenal hyperplasia","volume":"211","author":"Wei","year":"2021","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"11","key":"2025052406571769200_dgae201-B92","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.2174\/1871530323666230407125523","article-title":"Two cases with 17-alpha hydroxylase deficiency misdiagnosed as primary aldosteronism","volume":"23","author":"Akkus","year":"2023","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"7","key":"2025052406571769200_dgae201-B93","doi-asserted-by":"crossref","first-page":"e6109","DOI":"10.1002\/ccr3.6109","article-title":"17 alpha-hydroxylase deficiency: a case report of young Chinese woman with a rare gene mutation","volume":"10","author":"Han","year":"2022","journal-title":"Clin Case Rep"},{"issue":"2","key":"2025052406571769200_dgae201-B94","doi-asserted-by":"crossref","first-page":"e6962","DOI":"10.1002\/ccr3.6962","article-title":"Case report: management challenges of late diagnosed 17-alpha hydroxylase deficiency","volume":"11","author":"Ben Salah","year":"2023","journal-title":"Clin Case Rep"},{"issue":"1","key":"2025052406571769200_dgae201-B95","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/s12902-022-01216-y","article-title":"An elderly patient with 17\u03b1-hydroxylase deficiency misdiagnosed as primary aldosteronism: a case report","volume":"22","author":"Ishinoda","year":"2022","journal-title":"BMC Endocr Disord"},{"issue":"3","key":"2025052406571769200_dgae201-B96","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1210\/jcem-59-3-513","article-title":"Diagnosis and natural history of 17-hydroxylase deficiency in a newborn male","volume":"59","author":"Dean","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2025052406571769200_dgae201-B97","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/labmed\/lmac141","article-title":"A novel homozygous pathogenic variant in CYP11B1 in a female Iranian patient with 11B hydroxylase deficiency","volume":"54","author":"Hoseinzadeh","year":"2023","journal-title":"Lab Med"},{"issue":"11","key":"2025052406571769200_dgae201-B98","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1136\/adc.59.11.1092","article-title":"Salt loss in congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency","volume":"59","author":"Hochberg","year":"1984","journal-title":"Arch Dis Child"},{"issue":"11","key":"2025052406571769200_dgae201-B99","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1210\/jcem.85.11.6897","article-title":"Bilateral laparoscopic adrenalectomy for congenital adrenal hyperplasia with severe hypertension, resulting from two novel mutations in splice donor sites of CYP11B1","volume":"85","author":"Chabre","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2025052406571769200_dgae201-B100","doi-asserted-by":"crossref","first-page":"812","DOI":"10.3390\/ijms19030812","article-title":"Liddle syndrome: review of the literature and description of a new case","volume":"19","author":"Tetti","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"11","key":"2025052406571769200_dgae201-B101","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/jch.12598","article-title":"Prevalence of liddle syndrome among young hypertension patients of undetermined cause in a Chinese population","volume":"17","author":"Wang","year":"2015","journal-title":"J Clin Hypertens Greenwich Conn"},{"key":"2025052406571769200_dgae201-B102","volume-title":"Harrison's Principles of Internal Medicine","author":"Mount","year":"2022","edition":"21st ed"},{"issue":"4","key":"2025052406571769200_dgae201-B103","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1053\/j.ajkd.2021.12.016","article-title":"Metabolic alkalosis pathogenesis, diagnosis, and treatment: core curriculum 2022","volume":"80","author":"Do","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"2025052406571769200_dgae201-B104","volume-title":"Greenspan's Basic & Clinical Endocrinology","author":"Young","year":"2017","edition":"10th ed"},{"issue":"4","key":"2025052406571769200_dgae201-B105","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/ng0895-394","article-title":"Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase","volume":"10","author":"Mune","year":"1995","journal-title":"Nat Genet"},{"issue":"5","key":"2025052406571769200_dgae201-B106","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1210\/jcem-49-5-757","article-title":"A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol","volume":"49","author":"Ulick","year":"1979","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2025052406571769200_dgae201-B107","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s12020-020-02460-9","article-title":"Apparent mineralocorticoid excess caused by novel compound heterozygous mutations in HSD11B2 and characterized by early-onset hypertension and hypokalemia","volume":"70","author":"Fan","year":"2020","journal-title":"Endocrine"},{"issue":"17","key":"2025052406571769200_dgae201-B108","doi-asserted-by":"crossref","first-page":"10200","DOI":"10.1073\/pnas.95.17.10200","article-title":"A genetic defect resulting in mild low-renin hypertension","volume":"95","author":"Wilson","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"2025052406571769200_dgae201-B109","doi-asserted-by":"crossref","first-page":"e924","DOI":"10.1210\/clinem\/dgz315","article-title":"Classic and nonclassic apparent mineralocorticoid excess syndrome","volume":"105","author":"Carvajal","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"1\u20133","key":"2025052406571769200_dgae201-B110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0960-0760(93)90114-C","article-title":"Congenital and acquired syndromes of apparent mineralocorticoid excess","volume":"45","author":"Edwards","year":"1993","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"4-6","key":"2025052406571769200_dgae201-B111","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/0022-4731(87)90158-0","article-title":"Glycyrrhizic acid and its hydrolysate as mineralocorticoid agonist","volume":"27","author":"Takeda","year":"1987","journal-title":"J Steroid Biochem"},{"issue":"1","key":"2025052406571769200_dgae201-B112","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0960-0760(94)90304-2","article-title":"Inhibition of 11 beta-hydroxysteroid dehydrogenase obtained from Guinea pig kidney by furosemide, naringenin and some other compounds","volume":"49","author":"Zhang","year":"1994","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2025052406571769200_dgae201-B113","doi-asserted-by":"crossref","first-page":"105605","DOI":"10.1016\/j.jsbmb.2020.105605","article-title":"Molecular mechanisms of posaconazole- and itraconazole-induced pseudohyperaldosteronism and assessment of other systemically used azole antifungals","volume":"199","author":"Beck","year":"2020","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"5","key":"2025052406571769200_dgae201-B114","first-page":"963","article-title":"Cortisol inactivation overload: a mechanism of mineralocorticoid hypertension in the ectopic adrenocorticotropin syndrome","volume":"74","author":"Ulick","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2025052406571769200_dgae201-B115","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1749-6632.2002.tb04419.x","article-title":"Association of hypertension and hypokalemia with Cushing's syndrome caused by ectopic ACTH secretion: a series of 58 cases","volume":"970","author":"Torpy","year":"2002","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"2025052406571769200_dgae201-B116","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s12020-013-0141-6","article-title":"Familial Cushing syndrome due to thymic carcinoids in a multiple endocrine neoplasia type 1 kindred","volume":"47","author":"Li","year":"2014","journal-title":"Endocrine"},{"issue":"1","key":"2025052406571769200_dgae201-B117","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1157\/13114367","article-title":"[Ectopic Cushing's syndrome caused by a functioning pancreatic neuroendocrine tumour in a patient with von Hippel-Lindau disease]","volume":"27","author":"Ben\u00edtez Velazco","year":"2008","journal-title":"Rev Esp Med Nucl"},{"issue":"1","key":"2025052406571769200_dgae201-B118","first-page":"52","article-title":"A novel medical treatment of cushing's due to ectopic ACTH in a patient with neurofibromatosis type 1","volume":"11","author":"Bano","year":"2013","journal-title":"Int J Endocrinol Metab"},{"issue":"7","key":"2025052406571769200_dgae201-B119","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1177\/000313480807400714","article-title":"Presentation of a medullary endocrine neoplasia 2A kindred with Cushing's syndrome","volume":"74","author":"Zaydfudim","year":"2008","journal-title":"Am Surg"},{"issue":"1","key":"2025052406571769200_dgae201-B120","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF03343803","article-title":"Congenital deficiency of 11beta-hydroxysteroid dehydrogenase (apparent mineralocorticoid excess syndrome): diagnostic value of urinary free cortisol and cortisone","volume":"24","author":"Palermo","year":"2001","journal-title":"J Endocrinol Invest"},{"issue":"8","key":"2025052406571769200_dgae201-B121","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1093\/ajh\/hpy051","article-title":"Serum cortisol and cortisone as potential biomarkers of partial 11\u03b2-hydroxysteroid dehydrogenase type 2 deficiency","volume":"31","author":"Carvajal","year":"2018","journal-title":"Am J Hypertens"},{"key":"2025052406571769200_dgae201-B122","author":"Liddle syndrome"},{"key":"2025052406571769200_dgae201-B123","doi-asserted-by":"crossref","first-page":"681974","DOI":"10.3389\/fendo.2021.681974","article-title":"Detection of urinary exosomal HSD11B2 mRNA expression: a useful novel tool for the diagnostic approach of dysfunctional 11\u03b2-HSD2-related hypertension","volume":"12","author":"De Santis","year":"2021","journal-title":"Front Endocrinol"},{"issue":"1","key":"2025052406571769200_dgae201-B124","doi-asserted-by":"crossref","first-page":"17156","DOI":"10.1038\/s41598-021-96628-6","article-title":"Novel metabolomic profile of subjects with non-classic apparent mineralocorticoid excess","volume":"11","author":"Tapia-Castillo","year":"2021","journal-title":"Sci Rep"},{"issue":"5","key":"2025052406571769200_dgae201-B125","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing's syndrome: an endocrine society clinical practice guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2025052406571769200_dgae201-B126","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","article-title":"Consensus on diagnosis and management of Cushing's disease: a guideline update","volume":"9","author":"Fleseriu","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"2025052406571769200_dgae201-B127","doi-asserted-by":"crossref","first-page":"e182","DOI":"10.1210\/clinem\/dgad454","article-title":"Ovine CRH stimulation and 8 mg dexamethasone suppression tests in 323 patients with ACTH-dependent Cushing's syndrome","volume":"109","author":"Elenius","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2025052406571769200_dgae201-B128","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1210\/JC.2015-1589","article-title":"Conventional and nuclear medicine imaging in ectopic Cushing's syndrome: a systematic review","volume":"100","author":"Isidori","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2025052406571769200_dgae201-B129","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/MBP.0000000000000583","article-title":"Apparent mineralocorticoid excess: a diagnosis beyond classical causes of severe hypertension in a child","volume":"27","author":"Gulhan","year":"2022","journal-title":"Blood Press Monit"},{"key":"2025052406571769200_dgae201-B130","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jsbmb.2016.02.014","article-title":"Apparent mineralocorticoid excess and the long term treatment of genetic hypertension","volume":"165","author":"Razzaghy-Azar","year":"2017","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"4","key":"2025052406571769200_dgae201-B131","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0039-128X(96)00012-8","article-title":"Apparent mineralocorticoid excess: type I and type II","volume":"61","author":"Mantero","year":"1996","journal-title":"Steroids"},{"issue":"12","key":"2025052406571769200_dgae201-B132","doi-asserted-by":"crossref","first-page":"e13030","DOI":"10.1111\/jne.13030","article-title":"Adrenalectomy in ectopic Cushing's syndrome: a retrospective cohort study from a tertiary care centre","volume":"33","author":"Lase","year":"2021","journal-title":"J Neuroendocrinol"},{"issue":"7","key":"2025052406571769200_dgae201-B133","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1210\/clinem\/dgab122","article-title":"Approach to the patient treated with steroidogenesis inhibitors","volume":"106","author":"Castinetti","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2025052406571769200_dgae201-B134","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1210\/clinem\/dgaa778","article-title":"Adrenally directed medical therapies for Cushing syndrome","volume":"106","author":"Tritos","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2025052406571769200_dgae201-B135","doi-asserted-by":"crossref","first-page":"luae015","DOI":"10.1210\/jcemcr\/luae015","article-title":"Prolonged hypokalemia following metyrapone treatment for primary bilateral macronodular adrenal cortical disease","volume":"2","author":"Kidawara","year":"2024","journal-title":"JCEM Case Rep"},{"issue":"6","key":"2025052406571769200_dgae201-B136","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1210\/clinem\/dgac691","article-title":"Efficacy and safety of osilodrostat in paraneoplastic Cushing syndrome: a real-world multicenter study in France","volume":"108","author":"Dormoy","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"2025052406571769200_dgae201-B137","article-title":"Hypokalemia associated with mifepristone use in the treatment of Cushing's syndrome","volume":"2019","author":"Sai","year":"2019","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"4","key":"2025052406571769200_dgae201-B138","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S2213-8587(18)30155-4","article-title":"Advances in the medical treatment of Cushing's syndrome","volume":"7","author":"Feelders","year":"2019","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgae201\/57243037\/dgae201.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/109\/7\/1694\/58235482\/dgae201.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/109\/7\/1694\/58235482\/dgae201.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T06:57:45Z","timestamp":1748069865000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/109\/7\/1694\/7636628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,28]]},"references-count":138,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,3,28]]},"published-print":{"date-parts":[[2024,6,17]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgae201","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,7]]},"published":{"date-parts":[[2024,3,28]]}}}